These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20806222)

  • 1. Structural facets of disease-linked human prion protein mutants: a molecular dynamic study.
    Rossetti G; Giachin G; Legname G; Carloni P
    Proteins; 2010 Dec; 78(16):3270-80. PubMed ID: 20806222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation.
    Biljan I; Ilc G; Giachin G; Raspadori A; Zhukov I; Plavec J; Legname G
    J Mol Biol; 2011 Sep; 412(4):660-73. PubMed ID: 21839748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dynamics study of the dominant-negative E219K polymorphism in human prion protein.
    Jahandideh S; Jamalan M; Faridounnia M
    J Biomol Struct Dyn; 2015; 33(6):1315-25. PubMed ID: 25027605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR structural studies of human cellular prion proteins.
    Biljan I; Ilc G; Giachin G; Legname G; Plavec J
    Curr Top Med Chem; 2013; 13(19):2407-18. PubMed ID: 24059340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
    Liemann S; Glockshuber R
    Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for the protective effect of the human prion protein carrying the dominant-negative E219K polymorphism.
    Biljan I; Giachin G; Ilc G; Zhukov I; Plavec J; Legname G
    Biochem J; 2012 Sep; 446(2):243-51. PubMed ID: 22676969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90-231.
    Apetri AC; Vanik DL; Surewicz WK
    Biochemistry; 2005 Dec; 44(48):15880-8. PubMed ID: 16313190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational studies on prion proteins: effect of Ala(117)-->Val mutation.
    Okimoto N; Yamanaka K; Suenaga A; Hata M; Hoshino T
    Biophys J; 2002 May; 82(5):2746-57. PubMed ID: 11964260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common structural traits across pathogenic mutants of the human prion protein and their implications for familial prion diseases.
    Rossetti G; Cong X; Caliandro R; Legname G; Carloni P
    J Mol Biol; 2011 Aug; 411(3):700-12. PubMed ID: 21689662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the pathological Q212P mutation on human prion protein non-octarepeat copper-binding site.
    D'Angelo P; Della Longa S; Arcovito A; Mancini G; Zitolo A; Chillemi G; Giachin G; Legname G; Benetti F
    Biochemistry; 2012 Aug; 51(31):6068-79. PubMed ID: 22788868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalent mutations of human prion protein: a molecular modeling and molecular dynamics study.
    Behmard E; Abdolmaleki P; Asadabadi EB; Jahandideh S
    J Biomol Struct Dyn; 2011 Oct; 29(2):379-89. PubMed ID: 21875156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Horse prion protein NMR structure and comparisons with related variants of the mouse prion protein.
    Pérez DR; Damberger FF; Wüthrich K
    J Mol Biol; 2010 Jul; 400(2):121-8. PubMed ID: 20460128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biology and genetics of prion diseases.
    Prusiner SB
    Annu Rev Microbiol; 1994; 48():655-86. PubMed ID: 7826022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The unfolded state of the murine prion protein and properties of single-point mutants related to human prion diseases.
    Gerum C; Schlepckow K; Schwalbe H
    J Mol Biol; 2010 Aug; 401(1):7-12. PubMed ID: 20541558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biology and genetics of prion diseases.
    Prusiner SB
    Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):447-63. PubMed ID: 7913765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics studies on the NMR and X-ray structures of rabbit prion proteins.
    Zhang J; Zhang Y
    J Theor Biol; 2014 Feb; 342():70-82. PubMed ID: 24184221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptides and proteins in neurodegenerative disease: helix propensity of a polypeptide containing helix 1 of the mouse prion protein studied by NMR and CD spectroscopy.
    Liu A; Riek R; Zahn R; Hornemann S; Glockshuber R; Wüthrich K
    Biopolymers; 1999; 51(2):145-52. PubMed ID: 10397798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural rearrangements at physiological pH: nuclear magnetic resonance insights from the V210I human prion protein mutant.
    Biljan I; Ilc G; Giachin G; Plavec J; Legname G
    Biochemistry; 2012 Sep; 51(38):7465-74. PubMed ID: 22947063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico analysis of prion protein mutants: a comparative study by molecular dynamics approach.
    Doss CG; Rajith B; Rajasekaran R; Srajan J; Nagasundaram N; Debajyoti C
    Cell Biochem Biophys; 2013; 67(3):1307-18. PubMed ID: 23723004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.